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Mesenchymal stem cells (MSCs), the archetypal mul-
tipotent progenitor cells derived in cultures of devel-
oped organs, areof unknown identityandnativedistri-
bution. We have prospectively identified perivascular
cells, principally pericytes, in multiple human organs
including skeletal muscle, pancreas, adipose tissue,
and placenta, on CD146, NG2, and PDGF-Rb expres-
sion and absence of hematopoietic, endothelial, and
myogenic cell markers. Perivascular cells purified
from skeletal muscle or nonmuscle tissues were myo-
genic in culture and in vivo. Irrespective of their tissue
origin, long-term cultured perivascular cells retained
myogenicity; exhibited at the clonal level osteogenic,
chondrogenic, and adipogenic potentials; expressed
MSC markers; and migrated in a culture model of che-
motaxis. Expression of MSC markers was also de-
tected at the surface of native, noncultured perivascu-
lar cells. Thus, blood vessel walls harbor a reserve of
progenitor cells that may be integral to the origin of
the elusive MSCs and other related adult stem cells.
INTRODUCTION
Subsets of cells that participate in the architecture of blood ves-
sels exhibit developmental potentials beyond angiogenesis.
Vascular endothelium generates hematopoietic cells in the em-
bryo (Jaffredo et al., 1998; Oberlin et al., 2002; Zambidis et al.,
2006), and multipotent mesoangioblasts have been derived
from the embryonic aorta and other blood vessels (DeAngelis
et al., 1999; Cossu and Bianco, 2003; LeGrand et al., 2004). Peri-
cytes, aka Rouget cells or mural cells, also called mesangial cells
in the kidney and Ito cells in the liver, closely encircle endothelialCell Scells in capillaries and microvessels (Andreeva et al., 1998).
Some contain a-smooth muscle actin (a-SMA) and regulate mi-
crovessel contractility (Nehls and Drenckhan, 1991; Boado and
Pardridge, 1994). Pericytes can also inhibit, via TGF-b activation,
the division of endothelial cells (reviewed in Betsholtz et al.,
2005). In addition, pericytes are believed to include progenitors
of different cell types, although this assumption relies mostly
on indirect evidence. In one study, bovine retinal pericytes
implanted in diffusion chambers in nude mice differentiated
into chondrocytes and adipocytes (Farrington-Rock et al.,
2004). Pericytes are also believed to be osteogenic and, there-
fore, be responsible for the pathologic calcification of blood ves-
sels, heart valves, and skeletal muscle (reviewed in Collett and
Canfield, 2005). The appearance, in pericyte-rich cultures of hu-
man dental pulp, of dentin-expressing cells also suggested that
odontoblasts can be derived from perivascular cells (Alliot-Licht
et al., 2005). However, each of the aforementioned differentiation
experiments was performed on pericyte-containing cultures and
not on purified pericytes. As a recent exception, Dellavalle et al.
(2007) have demonstrated that pericytes sorted from human skel-
etal muscle by alkaline phosphatase expression can regenerate
skeletal myofibers in dystrophic immunodeficient mice. Mesoan-
gioblasts, the blood vessel-associated myogenic stem cells pre-
viously identified in vitro (DeAngelis et al., 1999), may therefore be
related to perivascular cells. Some of us have previously discov-
ered in ‘‘preplate’’ cultures of skeletal muscle a similar population
of muscle-derived stem cells (MDSCs) of unknown identity that
regenerate myofibers more efficiently than committed satellite
cells (Qu-Petersen et al., 2002; Pe´ault et al., 2007). Mesoangio-
blasts and MDSCs may be related to other elusive, multilineage
progenitor cells encountered in bone marrow and other tissues,
such as MSCs (mesenchymal stem cells) (Caplan, 1991; Pittenger
et al., 1999) and multipotent adult progenitor cells (MAPCs) (Jiang
et al., 2002). White adipose tissue (WAT) also contains progeni-
tors of multiple mesodermal cell lineages and is therefore an
attractive source of autologous cells for transplantation. Zuktem Cell 3, 301–313, September 11, 2008 ª2008 Elsevier Inc. 301
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Multipotent Human Perivascular Cellset al. (2002) found a putative MSC population in human WAT and
drove its differentiation into adipocytes, osteoblasts, chondro-
cytes, and myoblasts. Gronthos et al. (2001) further showed sim-
ilarities between human WAT stroma vascular cells and bone
marrow stromal cells. Whether these multipotent cells, all of
which were isolated retrospectively in culture, share a common
ancestor in multiple developed organs is unknown. In order to
further explore the presence of multilineage progenitors among
human perivascular cells, we first validated a combination of
markers to typify these cells, which were then purified from skel-
etal muscle, pancreas, adipose tissue, and other organs. We
demonstrate that human perivascular cells, pericytes in particu-
lar, are myogenic in vivo and ex vivo, irrespective of their tissue
of origin. Moreover, human perivascular cells sorted from diverse
human tissues and cultured over the long term give rise to adher-
ent, multilineage progenitor cells that exhibit the features of MSC.
RESULTS
Immunohistochemical Detection of Perivascular
Cells in Human Tissues
As a prerequisite to human perivascular cell sorting by flow cytom-
etry, we used immunohistochemistry to establish a relevant com-
bination of markers for this elusive cell population. To this end, we
examined each of the following: (1) ten adult (16–78 years of age)
and 18 fetal skeletal muscle samples (16–24 weeks of gestation);
(2) 5 adult (33–61 years) and 6 fetal pancreases (17–24 weeks);
(3) 28 placentas (20 at 17–24 weeks and 8 at term); and (4) 15 adult
WAT as well as (5) 3 fetal hearts, 3 fetal skins, 5 lungs, 1 brain, 2
eyes, 1 gut, 1 bone marrow, and 3 term umbilical cords. In all
organs, we observed the ubiquitous expression, by perivascular
cells surrounding capillaries (diameter <10 mm) and arterioles (di-
ameter from 10 to 100 mm), of NG2, a proteoglycan associated
with pericytes during vascular morphogenesis (Ozerdem et al.,
2002) and CD146 (aka S-endo1, Mel-CAM, Muc18, or gicerin),
an endothelial cell antigen also expressed at the surface of peri-
cytes (Li et al., 2003; Middleton et al., 2005; Sacchetti et al.,
2007) (Figures 1A–1C and 1G). CD146 was indeed present on en-
dothelium in capillaries, but not on microvessel endothelial cells
(data not shown). CD146 was also detected on perivascular cells
around venules. In order to ascertain that CD146+ cells detected
around small vessels are indeed pericyte-like cells, tissue sec-
tions were double stained with antibodies to CD146 and NG2.
As illustrated by Figures 1G–1I, CD146+ perivascular cells are
also positive for NG2 expression. Furthermore, all perivascular
cells express PDGF-Rb (Figure 1D), and a-SMA was reproducibly
detected in cells surrounding venules and arterioles, but not
around most capillaries (Figure 1F and data not shown). In con-
trast, perivascular cells do not express endothelial cell markers
such as CD144 (VE-cadherin) (Figure 1E), von Willebrand factor
(vWF) (Figure1D), CD34 (Figures 1A–1C), theUlexeuropaeus lectin
ligand (Figure 1F), or CD31 (data not shown). The same pericyte/
perivascular cell phenotype was found in all other human organs
and tissues tested. Most importantly, cells exhibiting this surface
phenotype were, in all tissues analyzed, exclusively perivascular.
Flow Cytometry Sorting of Perivascular Cells
We next proceeded to analyze and sort perivascular cells by
using multicolor fluorescence-activated cell sorting (FACS).302 Cell Stem Cell 3, 301–313, September 11, 2008 ª2008 ElsevierTwenty-eight fetal (17–23 weeks), 6 adult skeletal muscles (50–
78 years), and 8 fetal myocardiums (17–22 weeks) were first pro-
cessed independently. Twenty fetal (19–22 weeks) and 8 term
placentas were also used since microdissected placental blood
vessels transplanted intact into SCID/mdx mouse muscles re-
generated myofibers (data not shown). Eight fetal (17–23 weeks)
and 2 adult human pancreases, 2 fetal skins, 4 fetal brains, 24
fetal bone marrows, and 32 adult WAT samples were used as or-
gans devoid of regular myogenic cells. CD56+ cells were initially
gated out of muscle cell suspensions in order to avoid contami-
nation by regular myogenic cells (Pe´ault et al., 2007) and later on
eliminated from all tissues used for FACS analysis and sorting
(Figure 2B), as were hematopoietic cells (CD45+) (Figure 2C).
Perivascular cells were identified and sorted by high CD146 ex-
pression and lack of CD34, the latter in order to ascertain the ab-
sence of endothelial cells within sorted cells. The same popula-
tion of CD146+ CD34 CD45 CD56 cells was detected in all
tissues analyzed (Figures 2D–2J), amounting to 0.88% ± 0.18%
in fetal skeletal muscle, 0.29% ± 0.09% in adult skeletal muscle,
1.4% ± 0.33% in fetal pancreas, 0.65% ± 0.10% in adult pan-
creas, and 1.79% ± 1.10% in placenta. These cells were more
frequent in adipose tissue (14.6% ± 1.02%; Figure 2F), since
analysis was performed on the stromal vascular fraction, which
is markedly enriched in blood vessels. Perivascular cells from
multiple tissues were also observed to express alkaline phos-
phatase (Figures 2K–2N), a marker used recently to typify peri-
cytes in human skeletal muscle (Dellavalle et al., 2007). Sorted
perivascular cells were confirmed by RT-PCR analysis in each
experiment, not to include detectable hematopoietic cells
(CD34, CD45), endothelial cells (CD34, vWF) or regular myogenic
cells (CD56, Pax7) (data not shown).
Generalized Myogenic Potential of Perivascular Cells
Perivascular cells sorted from four distinct fetal skeletal muscles
were first tested for myogenic potential in culture. Sorted cells
were cultured for 8–10 days in muscle proliferation medium,
then for 5–10 more days in muscle fusion medium. Typical myo-
tubes containing three to five nuclei appeared after 8–10 days
and further developed, enclosing up to 15 nuclei 10 days later.
All myotubes developed in these conditions expressed human
myosin heavy chain (Figure 3A), desmin (Figure 3B), and dystro-
phin (Figure 3C). Perivascular cells sorted from human muscle
were then injected into the skeletal muscles of immunodeficient
SCID-NOD mice that had been injured by intramuscular injection
of cardiotoxin. Three weeks later, immunohistochemistry on
injected muscle sections revealed the presence of myofibers
expressing human spectrin (Figure 3D). A fluorescent probe for
a human pancentromeric sequence was hybridized on some
chimeric muscle sections, confirming the presence of central
human nuclei within human spectrin expressing, regenerating
myofibers (Figure 3D, insert). These results confirmed that peri-
vascular cells sorted stringently from human skeletal muscle
are endowed with myogenic potential. In three independent
experiments, the myogenic potentials in vivo of freshly sorted
perivascular cells (CD146high CD45 CD34 CD144 CD56),
myoblasts (CD146 CD45 CD34 CD144 CD56+) and total
skeletal muscle cells were compared. These three populations
generated, respectively, 20.1 ± 11.9, 13.3 ± 5.7, and 3.0 ±
2.5 myofibers expressing human spectrin per 103 cells injectedInc.
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Multipotent Human Perivascular CellsFigure 1. Immunodetection of Perivascular Cells in Human Organs
Sections were indirectly immunostained with antibodies to mural and endothelial cell markers. (A) Myocardium: a capillary endothelial cell in transverse section
marked by CD34 expression (green) is closely surrounded by a CD146+ pericyte (red) (3900). (B) Skeletal muscle: small vessel transverse section; CD146+ peri-
vascular cells (green) surround CD34+ endothelial cells (red) (3400). (C) Placental villus: arterioles (A), venules (V), and capillaries (C) are all lined with CD34+
endothelial cells (green) surrounded by CD146+ perivascular cells (3100). (D) Skeletal muscle: small vessel longitudinal section; PDGF-Rb-positive perivascular
cells (red; red arrows) surround vWF+ endothelial cells (green; green arrows) (3400). (E) Fetal pancreas: small vessel longitudinal section; NG2-positive perivas-
cular cells (green; green arrows) surround CD144+ endothelial cells (red; red arrows) (3400). (F) Transverse and longitudinal sections of placental small blood
vessels. Endothelial cells marked by the Ulex europaeus lectin (red) are surrounded by perivascular cells expressing a-SMA (green) (3400). (G–I) Transverse sec-
tion of a skeletal muscle blood vessel double stained with antibodies to CD146 (G) and NG2 (H). (G) and (H) have been merged to create (I). Perivascular cells
marked by CD146 expression also express NG2. Cells in a more central location express exclusively CD146 (arrows) and likely represent endothelial cells
(3300). (A) Fetal myocardium; (B, D, G–I) skeletal muscle; (E) fetal pancreas; (C and F) placenta. Nuclei have been labeled blue with DAPI.into the cardiotoxin conditioned mouse muscle (Figure 3H,
red columns). Sorted perivascular cells produced at least as
many myofibers as did purified CD56+ myoblasts, which rules
out the possibility that the myogenic potential observed in
the former is a consequence of their contamination by rare
myoblasts.
These results indicate that at least some mural cells associ-
ated with muscle blood vessels are endowed with myogenic po-
tential and may play a role in muscle ontogeny and regeneration,
and confirm recently published results (Dellavalle et al., 2007).
The important question as to whether this myogenic potential
can be generalized to perivascular cells residing in nonmuscle
tissues was then addressed by examining, in a similar experi-
mental setting, mural cells extracted from pancreas, WAT, and
placenta. CD146high CD34 CD45 CD56 cells were sorted
from four placentas, 25 WAT samples, and 5 fetal pancreases
along an antigen profile very similar to that encountered in theCell Sskeletal muscle (Figures 2E, 2F, and 2I). Purity of the sorted cells
was confirmed by RT-PCR analysis (data not shown). Strikingly,
placenta-, WAT- and pancreas-derived perivascular cells also
exhibited potential, as did skeletal muscle perivascular cells, to
generate myotubes in culture (data not shown) and to yield hu-
man dystrophin- and spectrin-expressing myofibers upon trans-
plantation into SCID-mdx (Figure 3G) or cardiotoxin-treated
SCID-NOD mouse muscles (Figures 3E and 3F). The muscle
regeneration index of fat-derived perivascular cells was even
higher than that of muscle perivascular cells assayed in the
same conditions (Figure 3H, yellow bars).
Cultured Perivascular Cells Retain Myogenic Potential
and Exhibit Migratory Ability
Since both mesoangioblasts and MDSC are culture-adapted cell
lines (Qu-Petersen et al., 2002; Cossu and Bianco, 2003), we
next asked whether purified perivascular cells can be culturedtem Cell 3, 301–313, September 11, 2008 ª2008 Elsevier Inc. 303
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Multipotent Human Perivascular CellsFigure 2. Flow Cytometry Analysis and Sorting of Perivascular Cells
Fresh tissues were dissociated enzymatically, and cell suspensions were stained with directly or indirectly labeled antibodies and run on a FACSAria cell sorter.
Following double-scatter cell selection (A) and exclusion of CD56+ cells (B) and CD45+ cells (C), CD146high CD34 perivascular cells were sorted inside the gates
represented in red. A similar cell subset was detected and sorted in skeletal muscle (D), placenta (E), adipose tissue (F), skin (G), myocardium (H), pancreas (I), and
bone marrow (J). (A), (B), and (C) are from skeletal muscle. In box II, perivascular cells were identified (red gates) as described above in adipose tissue (K) and
muscle (M). Additional staining of the same cell suspensions with an anti-ALP antibody revealed that virtually all perivascular cells coexpress ALP (L and N).over the long term and still sustain myogenic potential. Perivas-
cular cells sorted from fetal and adult muscle, midterm placenta,
fetal skin, fetal pancreas, bone marrow, and adipose tissue and
subsequently seeded into culture adhered and proliferated in
a similar manner. Subconfluent perivascular cells generally ex-
hibited an elongated, grossly rectangular shape and displayed
short arms at their smaller ends (Figure 4A). At confluence, cells
were more polygonal (Figure 4B). Contact inhibition was not ob-
vious, since cells at confluence occasionally grew into spherical
structures above the plastic adherent monolayer (data not
shown). Figure 4C illustrates the cumulative number of popula-
tion doublings (PDs) during 20 weeks of continuous perivascular
cell culture from a 23-week-old fetal muscle: sorted cells could304 Cell Stem Cell 3, 301–313, September 11, 2008 ª2008 Elsevier Iundergo more than 40 PDs before the onset of senescence.
We calculated the perivascular cell population doubling time
(PDT) as previously described (Deasy et al., 2005). Growth was
slow in the first 6 weeks: approximately one PD per week or
PDT = 162 hr. We observed the fastest growth rate during weeks
6–16 (approximately 5–13 passages), during which the PDT was
approximately 60 hr. After 17 weeks of culture, perivascular cell
growth again slowed down to a PDT of about 106 hr (Figure 4C).
The same growth kinetics was observed for perivascular cells
sorted from pancreas, skin, adipose tissue, and placenta (data
not shown). Gene expression in cultured perivascular cells was
analyzed by RT-PCR. After either 4, 8, or 14 passages, muscle-
derived perivascular cells stably expressed NG2, CD146, andnc.
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Multipotent Human Perivascular CellsFigure 3. Myogenic Potential of Perivascular Cells
Two thousand CD146+ CD56 CD34 CD45 cells sorted from skeletal muscle were seeded per well into a 48-well plate in myogenic culture conditions. Two
weeks later, numerous multinucleated muscle fibers expressing slow myosin heavy chain (MHC) (A,3100), desmin (B,3100), and dystrophin (C,3200) had de-
veloped. Nuclei have been labeled blue with DAPI. 53 103 perivascular cells sorted from skeletal muscle (D), pancreas (E), or 104 from WAT (F) were injected into
cardiotoxin-conditioned SCID-NOD mouse muscles. Three weeks later, recipient muscle frozen sections were stained with antibodies specific to human spectrin
(D and F) and human dystrophin (E). Numerous human spectrin- and dystrophin-expressing muscle fibers (red) are present (3200). In one experiment ([D], insert),
sections from a recipient mouse muscle were immunostained with an antibody to human spectrin, then exposed to a probe specific for a human pancentromeric
sequence. Hybridization products appear conspicuously (pink) in the central nuclei of human spectrin expressing myofibers (arrows). (G) 2.53 104 perivascular
cells sorted from the midgestation placenta were injected into dystrophin-deficient SCID-mdx mouse muscles that were harvested 4 weeks later. Frozen sections
were stained with antibodies to mouse/human dystrophin (green) and human lamin A/C (red). Clusters of human dystrophin-expressing myofibers are present,
and human cells reside near the regenerated myofibers (yellow). Nuclei have been labeled blue with DAPI (3200). (H) Red columns: unfractionated adult skeletal
muscle cells, myoblasts (CD146- CD45- CD34- CD56+), and perivascular cells (CD146high CD45 CD34 CD56) sorted therefrom were injected into the car-
diotoxin-treated skeletal muscles of SCID-NOD mice. Yellow columns: the same experiment was performed with the WAT unfractionated stromal vascular frac-
tion (SVF), endothelial cells (CD45 CD34+ CD56), or perivascular cells (CD146high CD45 CD34 CD56) purified from the same WAT. Three weeks later,
human spectrin-expressing myofibers were counted on sections of recipient mouse muscles, and the regeneration index was calculated as the number of human
myofibers produced per 103 donor cells injected (three independent experiments). Error bars represent the standard error of the mean.a-SMA, but not CD31, CD34, CD45, or CD144, excluding the
growth of contaminating endothelial or hematopoietic cells
(Figure 4D).
The migration of progenitor cells at the site of injured or miss-
ing tissue is logically important for successful organ recon-
struction. Degradation products of mammalian extracellular
matrix (ECM) are chemotactic for progenitor cells, both
in vivo and in culture (Reing et al., 2008). Cultured perivascular
cells exhibited strong chemotaxis toward both a papain andCella pepsin digest of ECM harvested from porcine urinary bladder
(UBM) (Figure 4E).
Importantly, perivascular cells extracted from either muscle,
placenta, or pancreas and cultured remained capable, at all pas-
sage times tested (5, 9, 11), of differentiating into myotubes in
culture (data not shown) and regenerating myofibers in vivo
(Figure 5A). Cultured perivascular cells from a 23 week fetal
muscle were efficiently infected with recombinant lentiviruses
encoding green fluorescent protein (GFP), close to 100%Stem Cell 3, 301–313, September 11, 2008 ª2008 Elsevier Inc. 305
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Multipotent Human Perivascular CellsFigure 4. Long-Term Culture of Purified Perivascular Cells
Perivascular cells sorted from skeletal muscle and seeded in culture adhere and proliferate ([A], 3400) to confluence ([B], 3100). (C) PDs during 20 weeks of
continuous muscle-derived perivascular cell culture. PDTs are indicated on the plot. The fastest growth rate is observed during weeks 6–16, (PDT of about
60 hr). (D) RT-PCR analysis was performed on perivascular cells sorted from the same muscle and cultured for 4, 8, and 14 passages (p4, p8, p14) and total fresh
dissociated skeletal muscle cells (tot) to detect expression of markers of endothelial cells (CD31, CD34, CD144), hematopoietic cells (CD45), and perivascular
cells (CD146, a-SMA, NG2). Only the latter are detected at all stages of the culture. (E) Perivascular cell migration toward pepsin-digested (left columns) and
papain-digested (right columns) ECM was measured in a chemotaxis chamber. Migrations in response to matrix degradation products (yellow columns) and con-
trol buffer (red columns) were compared. **p% 0.02 and *p% 0.05, respectively. The y axis represents the number of cells per well that have migrated through the
filter toward the chemoattractant.cultured cells expressing GFP upon transduction. When injected
into cardiotoxin-injured SCID-NOD mouse skeletal muscles,
GFP-transgenic cells gave rise to discrete green fluorescent
myofibers, confirming the myogenic potential of cultured
perivascular cells (Figure 5B).
Cultured Perivascular Cells Give Rise to MSCs
We assessed, by flow cytometry and RT-PCR, antigens
expressed by long-term cultured human perivascular cells (Fig-
ure 6). This confirmed that all perivascular cells still display,
over extended culture, the markers their ancestors natively ex-
pressed in the tissue of origin (CD146, a-SMA, NG2, PDGF-Rb,
alkaline phosphatase) and that no cells in these cultures express
markers of endothelial cells (CD34, CD144, CD31, and vWF), he-
matopoietic cells (CD45), or myogenic cells (myogenin, m-cad-
herin, myf-5, and Pax7) (Figures 6A–6C). We also investigated
the expression in these cultures of antigens that typify MSCs de-306 Cell Stem Cell 3, 301–313, September 11, 2008 ª2008 Elsevier Irived from human bone marrow. Intriguingly, cultured human
perivascular cells from either skeletal muscle, pancreas, adipose
tissue, placenta, bone marrow, or other organs expressed all
recognized markers of MSC, including CD10, CD13, CD44,
CD73, CD90, and CD105 (Figure 6A) as well as CD108 (Sema
L), CD109 (platelet activation factor), CD140b (PDGF-Rb),
CD164 (MGC 24), CD166 (ALCAM), CD318 (CDCP1), CD340
(HER-2), CD349 (frizzled-9), SSEA-4, and HLA-CL I (data not
shown). In contrast, cultured perivascular cells, similar to MSC,
do not express CD56, CD106, CD133, CD324 (E-cadherin),
CD326 (Ep-CAM), CD344 (frizzled-4), and HLA-DR (Figure 6
and data not shown). These results suggested that the elusive
MSCs are derived from perivascular cells. To further document
this possible affiliation, we explored whether the developmental
potential of cultured perivascular cells reflects that of MSCs.
Indeed, when cultured in appropriate inductive conditions, peri-
vascular cells from all tissue sources tested, including bonenc.
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Multipotent Human Perivascular CellsFigure 5. Multilineage Potential of Long-Term Cultured Perivascular Cells
(A) Twenty thousand perivascular cells sorted from skeletal muscle and cultured for 9 weeks were injected into the cardiotoxin-treated skeletal muscles of SCID-
NOD mice. Three weeks later, human spectrin-expressing myofibers generated by injected perivascular cells are present in the host muscle (red). Nuclei have
been labeled blue with DAPI (3200).
(B) 106 GFP-expressing cultured perivascular cells were injected into a cardiotoxin-damaged tibialis anterior skeletal muscle. Fourteen days later, clusters of
GFP-expressing myofibers (green) are present throughout the recipient muscle (330).
(C) Cultured perivascular cells were centrifuged into high-density cell pellets and cultivated in chondrogenic medium in the presence of TGF-b1. Twenty-one days
later, fixed pellet sections were stained with safranin O (320). (Insert) Pellet section stained with Alcian blue and nuclear fast red for the detection of s-GAG and
nuclei, respectively (3150).
(D) Cultured perivascular cells were further cultivated in adipogenic medium for 14 days, then fixed and incubated with Oil red O for detection of lipids (3250).
(E) Cells cultivated in osteogenic medium for 21 days were fixed and treated for the detection of alkaline phosphatase, then incubated in a 2.5% silver nitrate
solution (von Kossa staining). Alkaline phosphatase-positive cells are blue, and mineral deposits appear in black (3150).
(F) Cells cultivated in osteogenic medium as in (E) were incubated for 10 min in alizarin red at pH 4.2. Calcium deposits are stained in red (3150).
(G) Cultured perivascular cells immobilized in a Gelfoam sponge were implanted in a skeletal muscle pocket cut in the hind limb of a SCID-NOD mouse. X-ray
analysis, at day 30 after implantation, reveals a high-density area in the recipient muscle, demonstrating ectopic bone formation by the implanted cells.marrow, differentiated into chondrocytes (Figure 5C) and multi-
locular adipocytes (Figure 5D). Cultured perivascular cells also
gave rise to osteocytes in vitro (Figures 5E and 5F) and devel-
oped into bony nodules when transplanted into a skeletal muscle
pocket (Figure 5G) in an immunodeficient mouse. In order to as-
certain that individual cultured perivascular cells are multipotent,
cells from two independent cultures of muscle pericytes were
cloned by limiting dilution. For each starting pericyte population,
480 wells were seeded with single cells, out of which 120 and 48
clones developed, respectively (i.e., 25% and 10% of single
seeded perivascular cells grew clonally). Ten randomly chosenCell Sclones from each donor tissue were further cultured and split
to analyze separately adipogenic, chondrogenic, and osteo-
genic differentiation potentials. Each one of the 20 perivascular
cell clones analyzed differentiated into the three cell lineages,
demonstrating that cloned perivascular cells exhibit the typical
developmental potential of MSCs (data not shown).
Perivascular Cells Natively Express MSC Markers
Having shown that perivascular cells sorted to homogeneity from
diverse human organs yield in culture a progeny of MSCs, we
wished to determine whether this affiliation can be furthertem Cell 3, 301–313, September 11, 2008 ª2008 Elsevier Inc. 307
Cell Stem Cell
Multipotent Human Perivascular CellsFigure 6. Long-Term Cultured Perivascular Cells Express Markers of MSCs
(A) Cells were detached from the culture flask with trypsin, permeabilized with Triton X-100 when required, and stained with directly labeled monoclonal
antibodies (green histograms) or exposed to isotype-matched nonimmune directly labeled immunoglobulins (red histograms).
(B) Perivascular cells purified from skeletal muscle and cultured for 7 passages (9 weeks) were analyzed by RT-PCR. Presence of messengers expressed in
endothelial cells (CD34, CD144, CD31, and vWF), perivascular cells (CD146, a-SMA, NG2, PDGF-Rb), hematopoietic cells (CD45), MSC (CD90), and myogenic
progenitors (M-cadherin, myogenin, Myf5, and Pax7) was compared between cultured pericytes (P) and total muscle (control, C).
(C) Perivascular cells sorted from adult skeletal muscle and hWAT and cultured for 4 weeks were detached and double stained with antibodies to CD146
and ALP.supported by showing that mural cells, in their native perivascu-
lar arrangement within intact tissues, already express MSC
markers. To this end, antibodies to CD44, CD73, CD90, and
CD105 were added, in a five-color FACS analysis, to those
used to typify perivascular cells as described in Figure 2. One fe-
tal (23 weeks) and four adult skeletal muscles (56–86 years),
three midgestation and two term placentas, and two adult
WAT samples (27 and 42 years) were analyzed along this strat-
egy. CD146high CD34 CD45 CD56 perivascular cells were
found to express CD44, CD73, CD90, and CD105 (Figures
7A–7E), which was confirmed by immunohistochemical staining
of tissue sections (Figures 7F–7J). The perivascular location of
the cells expressing MSC markers was confirmed in confocal
microscopy by triple immunohistostaining with anti-CD146
(Figures 7I and 7J) and anti-a-SMA (data not shown).308 Cell Stem Cell 3, 301–313, September 11, 2008 ª2008 ElsevierDISCUSSION
We have refined the analysis and purification of cells that consti-
tute the human blood vessel wall. Confirming and extending pre-
vious observations (Ozerdem et al., 2002; Middleton et al., 2005;
Sacchetti et al., 2007), we have validated the CD146+ NG2+
PDGFRb+ ALP+ CD34 CD45 vWF CD144 phenotype as
an indicator of pericyte/perivascular cell identity throughout hu-
man fetal and adult organs. We demonstrate that perivascular
cells isolated prospectively from skeletal muscle and, less
expectedly, nonmuscle tissues are myogenic in culture and
in vivo. We can rule out that the myogenic potential present
in perivascular cells sorted from skeletal muscle is due to con-
tamination by regular myogenic cells since (1) no Pax7 or CD56
expression was ever detected by RT-PCR analysis withinInc.
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(Left column) The stromal vascular fraction isolated from human WAT was stained simultaneously with antibodies to perivascular cells and MSCs and analyzed by
flow cytometry. CD45 CD56 CD146high CD34 cells were gated (A) and analyzed for coexpression of CD44 (B), CD73 (C), CD90 (D), and CD105 (E). Clear
histograms in (B)–(E) represent control cells incubated with unrelated isotype-matched antibodies. (Middle column) Frozen sections of human WAT were cos-
tained with antibodies to CD34 (green) or von Willebrand factor (vWF, green) to reveal endothelial cells (green arrows) and either CD44 (red, [F]) or CD90 (red,
[G]. Pericytes lining small blood vessels express both CD44 (F) and CD90 ([G], main) (red arrows). Pericytes surrounding capillaries also strongly express
CD90 ([G], inlet 31000) (red arrow). (H) Frozen sections of adult human muscle were costained with antibodies to CD144 (red) to reveal endothelial cells (red
arrows) and CD73 (green). Pericytes lining the small blood vessel express CD73 ([H], 3600, green arrows). (Right column) Frozen sections of human WAT
were colabeled with antibodies to vWF (green), CD146 (purple), and CD73 ([I], red) or CD105 ([J], red). Confocal microscopy revealed that pericytes lining capil-
laries express both CD73 ([I],31000) and CD105 ([J],31000) in addition to CD146 (purple/red arrows). In contrast, endothelial cells express vWF and lower levels
of CD146 (I) (green/purple arrows) as well as CD105 (J) (green/purple/red arrows).extracts of freshly sorted cells or by immunocytochemistry on
the long-term cultured progeny thereof and (2) the average mus-
cle regeneration index of perivascular cells was at least as high
as that of CD56+ myogenic cells purified from the same muscles.
We also confirmed that cultured muscle pericytes, despite their
vigorous myogenic potential, do not express any known myo-
genic cell marker such as MyoD, myogenin, m-cadherin, myf-
5, and Pax7. This is an important point inasmuch as some acti-
vated myoblasts in fetal muscle express CD146 (Cerletti et al.,
2006). These results confirm that pericytes in human skeletal
muscle represent a myogenic cell compartment that is distinct
from that of satellite cells (Dellavalle et al., 2007) but, importantly,
also extend this potential to perivascular cells present inCellnonmuscle tissues such as pancreas, fat, bone marrow, and pla-
centa, indicating the existence of a ubiquitous myogenic poten-
tial throughout the organism. We suppose that this developmen-
tal potential is circumscribed to pericytes, i.e., perivascular cells
associated with capillaries and microvessels, which build up
most of, if not all, the vasculature in some of the tissues analyzed,
such as fetal pancreas, muscle, and WAT. However, the pres-
ence of myogenic progenitors at the periphery of larger veins
and arteries cannot be ruled out, since two of the pericyte
markers used in this work, NG2 and CD146, are also expressed
around larger blood vessels.
Multilineage progenitor cells have been previously identified in
multiple adult human and rodent tissues to include (1) MSCs,Stem Cell 3, 301–313, September 11, 2008 ª2008 Elsevier Inc. 309
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and cord blood and adipose tissue and can differentiate into me-
soderm lineage cells, including myoblasts (Caplan, 1991; Pit-
tenger et al., 1999); (2) muscle-derived MDSCs, which some of
us have previously characterized (Qu-Petersen et al., 2002;
Pe´ault et al., 2007); and (3) bone marrow-derived MAPCs, which
can contribute to mesodermal, endodermal, and ectodermal cell
lineages and have equivalents in mouse brain (Jiang et al., 2002),
pancreas (Seaberg et al., 2004), and dermis (Toma et al., 2001)
as well as in human skin (Shih et al., 2005) and WAT (Zuk et al.,
2002). The existence of all these adult multipotent progenitors
has been, however, revealed only retrospectively in long-term
cultures of the source tissues; therefore, their identity and ana-
tomic distribution in native organs could not be determined. Us-
ing a large panel of known and novel cell markers (Battula et al.,
2007; Gang et al., 2007), we observed that cultured perivascular
cells from a variety of tissues exhibit a phenotype that is strikingly
similar to that of MSCs derived from bone marrow. Moreover, we
show that long-term cultured perivascular cells sorted from
diverse fetal and adult tissues can differentiate into osteocytes,
chondrocytes, and adipocytes, which is the cardinal property
of MSCs. Most importantly, single cultured perivascular cells
seeded in vitro developed at high frequency into clones, which
all yielded osteocytes, chondrocytes, and adipocytes when
seeded in the appropriate differentiation conditions. This dem-
onstrates that each individual perivascular cell has multilineage
mesodermal potential and therefore adheres to the strict defini-
tion of a MSC. Conversely, our unpublished observations indi-
cate that the same cultured human perivascular cells can neither
differentiate into neural cells nor develop into teratomas when
transplanted into mouse brain and testis, respectively (data not
shown). These cells therefore appear to be developmentally
closer to MSCs than MAPCs or ESCs. In support of a perivascu-
lar origin of MSCs, we have also observed that perivascular cells
express natively, before culture, CD44, CD73, CD90, and
CD105, four surface molecules commonly used as MSC
markers. This indicates that perivascular cells—or a subset
thereof—have not merely acquired MSC antigens in culture but
natively expressed these markers, and therefore further sug-
gests a developmental affiliation between perivascular cells
and MSCs. Interestingly, Schwab and Gargett (2007) have also
suggested CD146 and PDGFRb as markers of MSC-like cells
in the endometrium, and Traktuev et al. (2008) described multi-
potent cells in WAT that coexpress some pericyte and MSC
markers; that cell subset is, however, marked by CD34 expres-
sion and therefore clearly distinct from the cells we describe
herein.
Overall, our data support the hypothesis that an ancestor of
the MSC is natively associated with the blood vessel wall and,
more precisely, belongs to a subset of perivascular cells (da Silva
Meirelles et al., 2008), even though it remains possible that some
MSCs originate in other cell subsets. The omnipresence of mural
cells would explain why such multilineage progenitors have been
found in a multitude of organs. In agreement, pericytes surround-
ing brain blood vessels constitutively express nestin, a marker of
neuronal progenitor cells (Alliot et al., 1999), and therefore may
play a role in neuronal regeneration. Chemoablated Leydig cells
in the rat testis are regenerated by adjacent vascular pericytes
which, during this process, transiently express nestin (Davidoff310 Cell Stem Cell 3, 301–313, September 11, 2008 ª2008 Elsevieret al., 2004). A study performed in mice also showed that peri-
vascular cells expressing Annexin 5 represent multilineage mes-
enchymal progenitors (Brachvogel et al., 2005). Interestingly,
a population of CD146+ subendothelial cells in human bone mar-
row contains osteogenic progenitors that are also at the origin of
the stromal cells that support hematopoiesis (Sacchetti et al.,
2007).
A physiological role of perivascular cells in human skeletal
muscle regeneration remains, however, to be formally demon-
strated, especially with respect to the observed presence of
a similar myogenic potential within pancreas, placenta, or fat.
Satellite cells are undifferentiated myoblasts that are integral to
myofiber regeneration during postnatal life (Morgan and Par-
tridge, 2003; Pe´ault et al., 2007), and experiments in quail-
chicken chimeras have revealed the origin of adult satellite cells
in the dermomyotome (Gros et al., 2005). This makes it unlikely
that, at least in birds, cells from the vessel wall contribute signif-
icantly to the pool of satellite cells.
On the other hand, we have recently identified a population of
myoendothelial cells in human skeletal muscle that coexpress
markers of both satellite and endothelial cells and exhibit robust
myogenic potential (Zheng et al., 2007). While the physiologic
role of vascular mesodermal progenitors in tissue development,
repair, and homeostasis remains to be elucidated, their practical
use to treat medical conditions can be already envisioned, since
these cells can be easily purified from convenient tissue sources
such as skeletal muscle and adipose tissue and multiplied in
culture to therapeutically relevant numbers with no significant
loss of developmental potential.
EXPERIMENTAL PROCEDURES
Human Tissues
Human fetal tissues were obtained following spontaneous, voluntary, or ther-
apeutic pregnancy interruptions performed at Magee-Womens Hospital (Uni-
versity of Pittsburgh), in compliance with Institutional Review Board protocol
number 0506176. Developmental age (16–24 weeks of gestation) was esti-
mated by measuring foot length. Informed consent for the use of fetal tissues
was obtained from patients in all instances. Adult human pancreas and muscle
were procured by the Center for Organ Recovery and Education (CORE, Pitts-
burgh) from multiorgan donors. Abdominal subcutaneous fat was obtained
anonymously from female patients (mean age of 51 years) undergoing abdom-
inoplasty at the Department of Surgery of the University of Pittsburgh Medical
Center.
Immunohistochemistry and Cytochemistry
Fresh tissues were gradually frozen by immersion in isopentane (Merck)
cooled in liquid nitrogen and embedded in tissue freezing medium (Triangle
Biomedical Sciences). WAT was impregnated in gelatin/sucrose and frozen
in the same conditions. Sections (5–9 mm) were cut on a cryostat (Microm)
and fixed for 5 min with 50% acetone (VWR International) and 50% methanol
(Fischer Chemical) or for 10 min in 4% paraformaldehyde (PFA, Sigma). Sec-
tions were dried for 5 min at room temperature (RT), washed three times for 5
min in PBS, and blocked with 5% goat serum (GIBCO) in PBS for 1 hr at RT.
Sections were incubated with uncoupled primary antibodies overnight at
4C or for 2 hr at RT in the case of directly coupled antibodies. After rinsing,
sections were incubated for 1 hr at RT with a biotinylated secondary antibody,
then with fluorochrome-coupled streptavidin, both diluted in 5% goat serum in
PBS. For intracellular stainings, cells were first permeabilized with PBS 0.1%
Triton X-100 (Sigma). Cultured cells were fixed inside wells as described
above, then washed three times in PBS 0.1% Triton X-100 and incubated for
1 hr in PBS, 5% goat serum. Cultured cells were then stained as described
above, in the presence of 0.1% Triton X-100. The following uncoupledInc.
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28D4; Monoclonal Antibody Facility of the University Clinic of Tu¨bingen, undi-
luted), anti-CD146 (BD Pharmingen, 1:100), anti-CD31 (DAKO, 1:100), anti-
CD34 (Serotec, 1:50), anti-CD44, anti-CD90 (both from Becton Dickinson
(BD), 1:20), anti-CD73 and anti-CD105 (both from Invitrogen, 1:50), anti-NG2
(BD Pharmingen, 1:300), and anti-lamin A/C (Novo Castra, 1:100). Coupled an-
tibodies used included the following: anti-CD146-Alexa 488 (Chemicon,
1:200), anti-a-SMA-FITC (Chemicon, 1:100), anti-CD34-FITC (DAKO, 1:50 or
Miltenyi, 1:20), anti-vWF-FITC (US Biological, 1:100), biotinylated anti-
CD144 (BD, 1:100), and biotinylated anti-CD146 (Miltenyi Biotec, 1:11). Strep-
tavidin-Cy3 (Sigma, 1:500) and Streptavidin-Cy5 (CyDye, 1:500) were used in
conjunction with biotinylated antibodies. Skeletal muscle proteins were de-
tected with anti-skeletal myosin heavy chain (fast) (Sigma 1:100), anti-skeletal
myosin heavy chain (slow) (Sigma 1:100), anti-spectrin and anti-dystrophin
(Novocastra, 1:20) and anti-desmin (1:50, Sigma). Rabbit anti-mouse dystro-
phin (Abcam, 1:100) was used to detect dystrophin positive myofibers in
SCID/mdx mice. Directly biotinylated Ulex europaeus lectin (UEA-1) was
also used as an endothelial cell marker (Vector, 1:200). Secondary goat anti-
mouse antibodies were biotinylated (DAKO and Immunotech, 1:1000) or cou-
pled to Alexa 488 (Molecular Probes, 1:500). Streptavidin-Cy3 (Sigma, 1:1000)
was used. Nuclei were stained with DAPI (40, 6-diamino-2-phenylindole dihy-
drochloride, Molecular Probes, 1:2000) for 5 min at RT. An isotype-matched
negative control was performed with each immunostaining. Slides were
mounted in glycerol-PBS (1:1, Sigma) and observed on an epifluorescence mi-
croscope (Nikon Eclipse TE 2000-U). Alternatively, sections were analyzed on
an Olympus Fluoview 1000 confocal microscope equipped with 1003 oil
immersion optics.
Fluorescent in situ hybridization, used in one experiment, is described in the
Supplemental Data available online.
Flow Cytometry
Fresh tissues were cut into small pieces in Dulbecco’s modified Eagle’s me-
dium (DMEM, GIBCO) containing 20% fetal calf serum (FCS, GIBCO), 1% pen-
icillin-streptomycin (PS, GIBCO), and collagenases I, II, and IV (1 mg/mL,
Sigma), then incubated at 37C for 1 hr on a shaker. Final cell dissociation
was achieved between ground glass slides. Adipose tissue was minced,
then digested in DMEM containing 3.5% bovine serum albumin (Sigma) and
collagenase II (1 mg/ml, Sigma) for 70 min under agitation at 37C. Mature
adipocytes were separated from pellets by centrifugation (2000 rpm, 10 min).
Pellets were resuspended in erythrocyte lysis buffer (155 mM NH4Cl, 10 mM
KHCO3, 0.1 mM EDTA) and incubated for 10 min at RT. Placenta was minced
and agitated in DMEM, 1% PS, and 1 mg/ml collagenases I, II, and IV (1 g tis-
sue/1 ml solution) for 30 min at 37C, 120 rpm; 0.05% trypsin (GIBCO) was
added, and the suspension was agitated for 10 min more. Cells were centri-
fuged and resuspended in DMEM, 1% PS. Cells were passed through a 70
mm cell strainer, centrifuged, and resuspended in erythrocyte lysis buffer
and incubated for 15 min at RT.
Cells from all tissues were then processed for immunofluorescence staining
as previously described (Zheng et al., 2007). Cells (105 for analysis and around
30 3 106 for sorting) were incubated with a combination of the following di-
rectly coupled mouse anti-human antibodies: anti-CD34-PE (DAKO, 1:100),
anti-CD45-APC-Cy7 (Santa Cruz Biotechnologies, 1:200), or anti-CD45-APC
(BD, 1:100), anti-CD56-PE-Cy7 and anti-CD146-FITC (Serotec, 1:100) in 1 ml
DMEM, 20% FCS, and 1% PS at 4C for 15 min in the dark. Cells were then
incubated for 15 min with 7-amino-actinomycin D (7-AAD, 1:100, BD) for
dead cell exclusion and run on a FACSAria flow cytometer (BD). Five-color
analysis of ALP and MSC marker expression by perivascular cells is described
in the Supplemental Data.
Cultured cells were labeled at different passages with the following commer-
cial antibodies: anti-CD13-PE, -CD34-PE, -CD44-FITC (BD), anti-CD45-PE-
Cy7 (Beckman Coulter), anti-CD56-PE (Chemicon), anti-CD73-PE (BD), anti-
CD90-PE (Chemicon), anti-CD105 FITC (ImmunoTools), anti-CD133-2-APC
(Miltenyi Biotec), anti-CD146-PE (BioCytex), anti-a-SMA-FITC (Sigma), anti-
HLA-ABC-FITC (Immunotech), and anti-HLA-DR-PE, -CXCR4, -NGF-R, and
-BB9 (BD), the latter being revealed with anti-mouse IgG1-FITC (Exalpha).
The following reagents from the monoclonal antibody facility of the University
Clinic of Tu¨bingen were also used for staining of cultured cells: anti-CD10
(CALLA; clone 97C5), anti-CD34 (clone 43A1), anti-CD56 (N-CAM; cloneCell S39D5), anti-CD105 (endoglin; clone 1G2C2), anti-CD109 (clone W7C5), anti-
CD133 (clone W6B1C3), anti-CD140b (PDGF-RB; clone 28D4), anti-CD164
(clone 67D2), anti-CD318 (CDCP1; clone CUB1), anti-CD324 (E-cadherin;
clone 67A4), anti-CD326 (Ep-CAM; clone 9C4), anti-CD340 (HER-2; clone
24D2), anti-CD344 (frizzled-4; clone CH3A4), and anti-CD349 (frizzled-9; clone
W3C4E11). Anti-CD166 was purchased from BD Pharmingen, and the PE con-
jugates against CD31, CD106, and CD108 were a kind gift from Dr. Gene Lay
(BioLegend, San Diego, CA). Full information on the human cell markers used
in this study can also be found at: http://www.hcdm.org. Isotype control
immunoglobulins used were IgG1-PE, IgG1-FITC (both from Chemicon),
IgG1-PE-Cy7 (Beckman Coulter), and IgG1-APC (BD). Resuspended cultured
cells were stained as follows. Cells were permeabilized with 0.1% Triton X-100
(Sigma) when necessary. After washing the cells twice with PBS containing 1%
FCS and 0.01% NaN3 (FACS buffer), cells were incubated with polyglobin to
block nonspecific binding. Cells were then incubated with the indicated
primary antibodies for 15 min on ice. After washing in FACS buffer, cells
were incubated with a F(ab)2 fragment of goat anti-mouse secondary antibody
conjugated with R-PE (Dako Cytomation) for 15 min. Finally, cells were washed
twice, and at least 50,000 events were acquired on a FACSCanto II cytometer
(BD), using FCS express software for analysis.
RT-PCR
Total RNA was extracted from 104 cells using the Absolutely RNA Nanoprep Kit
(Stratagene). cDNA was synthesized with SuperScript II reverse transcriptase
(Invitrogen). PCR was performed for 30 cycles at 58C annealing temperature
with Taq polymerase (Invitrogen), and PCR products were electrophoresed on
1% agarose gels. The primers used for PCR are listed in Table S1. Each set of
oligonucleotides was designed to span two different exons so that genomic
DNA contamination is of no concern.
Cell Culture and Gene Transduction
Sorted perivascular cells were seeded at 2 3 104 cells per cm2 in Endothelial
Cell Growth Medium 2 (EGM-2, Cambrex BioScience) and cultured at 37C for
2 weeks in plates coated with 0.2% gelatin (Calbiochem). Confluent cells were
then detached by treatment with trypsin-EDTA (GIBCO) for 10 min at 37C,
then split 1:3 in uncoated plates in DMEM high glucose (GIBCO), 20% FCS,
1% PS (GIBCO). After the fifth passage, cells were then passaged 1:6 in the
same conditions, and culture medium was changed every 4 days. We calcu-
lated the PDT as previously described (Deasy et al., 2005). Perivascular cells
were cloned in 96-well cloning plates (BD) by serial limiting dilution down to
a concentration of one cell/well in DMEM, 20% FCS. Medium was changed
twice a week. Plates were examined daily under the microscope in order to
evaluate cell growth. Each clone was expanded until enough cells were pres-
ent to test differentiation potentials as described below. For gene transfer, cul-
tured perivascular cells at passage 12 were detached with 0.25% trypsin/
EDTA and seeded at a density of 100,000 cells/cm2. After 16 hr, medium
was replaced with transduction medium (DMEM high glucose, 20% FCS,
1% PS, 8 mg/mL polybrene), and an EIAV-based CMV-driven eGFP expression
vector (Endo et al., 2007) was added at an moi of 100. After 3 days, nearly
100% of cells expressed GFP and were returned to culture medium.
Myogenesis in Culture
Cells (2 3 103 cells per cm2) were cultured for 7 days in proliferation medium
(DMEM high glucose, 10% FCS, 10% horse serum [HS, GIBCO], 1% CEE
[chicken embryo extract, Accurate], 1% PS) and then for 7–10 days in fusion
medium (DMEM high glucose, 1% FCS, 1% HS, 0.5% CEE, 1% PS [GIBCO]).
Half of the medium was renewed every 4 days. Myogenesis was induced
by lowering serum concentration to 2%, and medium was changed every
4 days until elongated, multinucleated myofibers appeared.
Muscle Regeneration In Vivo
Eight- to twelve-week old SCID-NOD mice were anaesthetized by inhalation of
isofluorane/O2. Cardiotoxin (15 mg; CTX, Molecular Probes) was injected into
the gastrocnemius muscle 3 hr prior to cell transplantation. Mice were rean-
aesthetized, and cells suspended in 35 ml PBS, or the same volume of PBS
as a control, were then slowly injected into the injured muscle. Mice were sac-
rificed 3 weeks later and muscle was harvested. Alternatively, 8- to 12-week
old dystrophic SCID-mdx mice were used as recipients. Muscles that hadtem Cell 3, 301–313, September 11, 2008 ª2008 Elsevier Inc. 311
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medium (Tissue-Tek, Sakura), and sectioned as 10 mm thick transverse sec-
tions. After three 15 min washes in PBS, slides were mounted with 50% glyc-
erol/DAPI solution. GFP was directly visualized by fluorescence microscopy
using both standard bandpass as well as ratiometric techniques to eliminate
background autofluorescence (Leica DMRBE).
Adipogenesis, Osteogenesis, and Chondrogenesis in Culture
For adipogenic differentiation, cultured cells at 70% confluence were switched
to DMEM, 10% FCS, 1 mM dexamethasone, 0.5 mM isobutylmethylxanthine,
60 mM indomethacine, and 170 mM insulin (all from Sigma-Aldrich). After
14 days, cells were fixed in 2% PFA at RT, washed in 60% isopropanol, and
incubated with oil red O for 10 min at RT for the detection of lipids.
For chondrogenesis, pellets were prepared by spinning down 3 3 105 cul-
tured cells and grown in serum-free DMEM containing an insulin-transferrin-
selenious (ITS) acid mix (BD Biosciences), 50 mg/ml L-ascorbic acid 2-phos-
phate (WAKO), 100 mg/ml sodium pyruvate, 40 mg/ml L-proline (both from
Invitrogen), 0.1 mM dexamethasone (Sigma-Aldrich), and 10 ng/ml transform-
ing growth factor b1 (TGF-b1; Peprotech). After 21 days, pellets were fixed in
10% formalin, dehydrated in ethanol, and embedded in paraffin. Sections 5 mm
thick were rehydrated and stained with Alcian blue and Nuclear Fast Red for
the detection of sulfated glycosaminoglycans and nuclei, respectively.
For in vitro bone formation, cells at 70% confluence were cultivated in
DMEM, 10% FCS, 0.1 mM dexamethasone, 50 mg/mL L-ascorbic acid, and
10 mM b-glycerophosphate. After 21 days, cells were fixed in 4% formalde-
hyde for 2 min and incubated for 10 min with alizarin red (pH 4.2) for the detec-
tion of calcium deposits. For detection of alkaline phosphatase activity, fixed
cells were incubated for 45 min in a mixture of naphtol AS-BI alkaline solution
with Fast Blue BB. Cells were then rinsed with deionized water and incubated
in a 2.5% silver nitrate solution for 30 min in order to detect mineral deposition
(all reagents from Sigma-Aldrich).
For osteogenesis in vivo, 53 105 cells in 100 ml were seeded on the surface
of a 63 6 mm piece of sterile gelatin sponge (Gelfoam), which was then placed
in a 24-well plate. After the cell suspension was absorbed, 3 ml of DMEM, 10%
FCS was added to the well, which was incubated overnight. The Gelfoam
scaffold was then implanted into a pocket in the gluteofemoral muscle of
a SCID-NOD mouse. X-ray analysis was performed 30 days later to evaluate
bone formation.
Cell Migration Assay
Cultured cells were starved for 15–18 hr in medium containing 0.5% FCS,
resuspended in serum-free medium at 6 3 105 cells/mL, and preincubated
for 1 hr at 37C. Polycarbonate chemotaxis filters (8 mm pore size, Neuro
Probe, Gaithersburg, MD) were coated with 0.05 mg/mL collagen I (BD Biosci-
ences, San Jose, CA). Pepsin or papain ECM degradation products (Reing
et al., 2008) were added to the bottom wells (100 ug/ml porcine urinary bladder
matrix [dry weight] pepsin digest and 100 ug/ml UBM papain digest) of a Neuro
Probe 48-well micro chemotaxis chamber (Neuro Probe Inc., Gaithersburg,
MD). Thirty thousand cells were then added to each upper well and placed
in the incubator for 3 hr. Nonmigrating cells on the top side of the membrane
were removed, and migrating cells on the bottom side were stained with Diff
Quik (Dade AG Liederbach, Germany). Three fields were counted from each
well. Each condition was tested in quadruplicate wells, and the average num-
ber of migrating cells was determined. Each experiment was repeated three
times. The Student’s t test was used to assess differences in cell migration
toward ECM degradation products and appropriate control buffer. P values
%0.05 were considered significant.
SUPPLEMENTAL DATA
The Supplemental Data include supplemental text and one table and can be
found with this article online at http://www.cellstemcell.com/cgi/content/full/
3/3/301/DC1/.
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